Niva Bupa Health Insurance Company Limited

Niva Bupa Health Insurance Company Ltd announced credit rating assignments from multiple agencies, including A.M. Best, which assigned a Financial Strength Rating of A- (Excellent) with a Stable outlook, a Long-Term Issuer Credit Rating of “a-” (Excellent) with a Stable outlook, and an India National Scale Rating (NSR) of aaa.IN (Exceptional) with a Stable outlook; A.M. Best also assigned a Financial Strength Rating of A- (Excellent) with a Stable outlook, a Long-Term Issuer Credit Rating of a- (Excellent) with a Stable outlook, and an India National Scale Rating (NSR) of aaa.IN (Exceptional) with a Stable outlook, alongside assessments of Operating Performance as Adequate, Return-on-Equity of 10.7% for fiscal-year 2026, a Combined Ratio of 102.0% for fiscal-year 2026 (net/net, IFRS 17), a Business Profile of Neutral, and Market Share as ranked third in the standalone health insurance sector, further noting integration with and majority ownership by Bupa Group and expectations for Bupa Group to provide capital support as needed, with additional information available through purchase.

Niva Bupa Health Insurance Company Limited announced changes to its senior management, effective September 16, 2026, including the transition of Mr. Vikas Jain from Chief Investment Officer to Chief Transformation Officer, a role he has held since October 2020, and the appointment of Mr. Karan Bhatia as Chief Investment Officer, bringing over 18 years of experience in the investment domain.

Niva Bupa Health Insurance Company Limited announced the allotment of 4,11,000 equity shares, comprised of 1,92,100 shares under the Niva Bupa Employee Stock Option Plan 2020 and 2,18,900 shares under the Niva Bupa Employee Stock Option Plan 2024, on August 26, 2026, following the exercise of options by eligible grantees; the allotment was approved by the Stakeholders Relationship Committee and increased the company's paid-up equity share capital to Rs 18,49,64,47,030.

Niva Bupa Health Insurance Company Ltd announced that ICRA Limited has reaffirmed its “[ICRA]AAA (Stable)” rating for the Issuer Rating and assigned “[ICRA]AA+(Stable)” ratings to the Subordinated Debt instruments amounting to Rs 500.00 crores and another subordinated debt instrument of 500.00, while also assigning a AAA rating to a Bank Loan of Rs 500 crore with surveillance due in one year; furthermore, ICRA has provided an initial rating of ICRA AA- to Tier II Bonds of Rs 500 Crore, noting that the rating reflects [further details from the text], and reaffirmed the Issuer Rating at [ICRA]AAA(Stable) with a total of -; finally, the rating agency noted that since no instrument is being rated, the Financial Sector Regulator is not applicable.

Net profit of Niva Bupa Health Insurance Company reported to Rs 137.80 crore in the quarter ended June 2026 as against net loss of Rs 91.44 crore during the previous quarter ended June 2025. Sales reported to Rs -2273.72 crore in the quarter ended June 2026 as against Rs 1220.00 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales-2273.721220.00 PL OPM %-8.10-7.62 - PBDT183.74-91.44 LP PBT183.74-91.44 LP NP137.80-91.44 LP Powered by Capital Market - Live

Niva Bupa Health Insurance Company Limited reported a Profit After Tax (PAT) of Rs 138 crore for the quarter ended June 30, 2026, a 93% year-on-year increase, according to a press release issued on Wednesday. The company’s Gross Written Premium (GWP) rose 32% to Rs 2,150 crore, while its retail health business grew 47%, increasing its Retail Health Market Share to 11.1%. Niva Bupa’s Claim Settlement Ratio improved to 95.6% and the Combined Insurance Service Ratio (CISR) improved to 100.2% from 103.2% in the previous year.

Niva Bupa Health Insurance Company will hold a meeting of the Board of Directors of the Company on 30 July 2026.

Niva Bupa Health Insurance Company announced that the 18th Annual General Meeting(AGM) of the company will be held on 12 August 2026.

Niva Bupa Health Insurance Company has allotted 14,76,432 equity shares under ESOP on 23 June 2026. Consequent to the aforesaid allotment, the paid-up equity share capital of the Company stands increased to Rs 18,49,23,37,030/- comprising 1,84,92,33,703 equity shares of face value of Rs 10/- each.

Marico Ltd, AAVAS Financiers Ltd, Blue Jet Healthcare Ltd, Cohance Lifesciences Ltd are among the other stocks to see a surge in volumes on BSE today, 11 June 2026.Niva Bupa Health Insurance Company Ltd recorded volume of 41.42 lakh shares by 10:46 IST on BSE, a 39.73 times surge over two-week average daily volume of 1.04 lakh shares. The stock gained 0.24% to Rs.84.39. Volumes stood at 1.16 lakh shares in the last session.Marico Ltd notched up volume of 5.74 lakh shares by 10:46 IST on BSE, a 13.5 fold spurt over two-week average daily volume of 42508 shares. The stock slipped 0.07% to Rs.819.35. Volumes stood at 89547 shares in the last session.AAVAS Financiers Ltd notched up volume of 6.12 lakh shares by 10:46 IST on BSE, a 7.71 fold spurt over two-week average daily volume of 79379 shares. The stock rose 1.81% to Rs.1,322.00. Volumes stood at 1.12 lakh shares in the last session.Blue Jet Healthcare Ltd saw volume of 1.59 lakh shares by 10:46 IST on BSE, a 7.5 fold spurt over two-week average daily volume of 21166 shares. The stock increased 8.38% to Rs.509.05. Volumes stood at 27050 shares in the last session.Cohance Lifesciences Ltd registered volume of 3.49 lakh shares by 10:46 IST on BSE, a 6.1 fold spurt over two-week average daily volume of 57243 shares. The stock slipped 1.36% to Rs.425.15. Volumes stood at 37906 shares in the last session.Powered by Capital Market - Live